NextGen Healthcare, Inc.
Extract: Update, Proxy Fight Director Nomination from a DFAN14A on 09/02/2021   Download
SEC Document
SEC Filing

Sheldon Razin (“Mr. Razin”), together with the other participants named herein, has filed a preliminary proxy statement and accompanying BLUE proxy card with the Securities and Exchange Commission (“SEC”) to be used to solicit votes for the election of his slate of highly-qualified director nominees at the 2021 annual meeting of stockholders (the “2021 Annual Meeting”) of NextGen Healthcare, Inc., a California corporation (the “Company”).

 

On September 2, 2021, Mr. Razin issued the following press release: